Novel CoFI device found to be safe and highly effective in detecting coronary microvascular obstruction (MVO) in the cathlab immediately after primary PCI PARIS--(BUSINESS WIRE)--CorFlow Therapeutics ...
In an exploratory cross-sectional study of 38 community-dwelling older adults, brief eye-tracking measures showed preliminary ...
A cross-sectional study of 300 adults aged 65 and older found that a higher CRP/albumin ratio was independently associated ...
I am concerned about memory loss in patients with heart failure, but I do not know when or how to evaluate it. This article ...
CorFlow Therapeutics AG, a clinical-stage company, has announced the interim positive results of its MOCA I (Microvascular Obstruction with CoFI System Assessment) study at EuroPCR in Paris, France.
Novel CoFI device found to be safe and highly effective in detecting coronary microvascular obstruction (MVO) in the cathlab immediately after primary PCI CorFlow Therapeutics AG, a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results